Three rounds of physical therapy.
Two epidural injections.
Gabapentin. Cymbalta. A medial branch block.
Then what?
If you can read that list and recognize most of it, this article is for you.
Read the Full Video Transcript
DISCLAIMER:
Transcript lightly edited for clarity and readability. The views expressed are intended to explore the full range of clinical considerations in spine care and do not constitute medical advice. Outcomes vary by patient and pain pattern. For guidance specific to your situation, consult a spine specialist.
TRANSCRIPT TEXT:
If you have already tried physical therapy, injections, and several different medications without lasting back pain relief, you are not at the beginning of this journey.
You are the patient modern spine care was built to help.
If you are sitting there nodding your head right now, feeling that deep exhaustion from trying treatment after treatment and still getting nowhere, we see you.
You have shown up. You have given treatments a fair chance. And yet, the pain may still be running the room in your life.
Welcome to this Vertrae® 360 explainer.
Today, we are taking a structured, highly visual look at the evolution of modern spine care. We are going to reframe how we think about chronic, treatment-resistant back pain.
We will break down why a long, frustrating medical history is not a dead end. In many cases, it can actually provide the key information needed to determine the next step.
Here is our roadmap for today:
One: the chronic pain journey.
Two: reframing resistance.
Three: matching care.
And four: the Vertrae® evaluation.
Let’s bring some order to what often feels like a chaotic medical maze.
The Chronic Pain Journey
Most patients with chronic back pain are handed a fairly standard playbook.
It often starts with rest and over-the-counter medications. Then the patient may be sent to physical therapy. If that plateaus, stronger medications or an injection may be recommended. And then, many patients are sent back to repeat the same cycle.
To be clear, this sequence can be completely reasonable at first. It helps many people.
But for patients whose pain has not responded, repeating the exact same loop for a fourth or fifth time often leads to the same frustrating plateau.
The data supports this pattern.
A large 2024 systematic review of 95 studies, including nearly 18,000 patients, found that low back pain lasting longer than 12 weeks tends to follow a specific course. Pain often improves modestly in the first six weeks, but after the 12-week mark, improvement commonly slows or plateaus.
Patients with persistent pain may see only small changes over the following year with usual care.
So if you have not made meaningful progress after 12 weeks, that does not mean you failed. It may simply reflect how chronic low back pain can behave when it remains stuck in the standard treatment loop.
Reframing Resistance: From Failure to Clues
Here is the first thing to know:
Patients who have tried the most are often the patients with the most diagnostic information.
Treatments that provide only temporary relief or do not produce lasting improvement are not necessarily failures. They are clues.
Let’s look at the phrase “treatment resistant.”
It can sound final, almost like a life sentence. But treatment resistant does not mean untreatable.
It simply means the pain has not responded in a lasting way to the usual first steps. It describes where the journey has gone, not what is still possible.
We need to flip the script from the old mindset to the new mindset.
The old way of thinking says, “If a treatment did not cure you, it failed.”
The newer, more useful mindset recognizes that you are not a blank slate. You bring hard-earned evidence to the table.
Every treatment response — even a partial or temporary one — may provide important diagnostic information about what to do next.
One of the most common things patients say in a spine consultation is, “It helped at first, but then it stopped.”
That can be incredibly frustrating. It gives you a taste of relief, only for the pain to return.
But temporary relief can be highly useful diagnostic data.
If a treatment helped for a while and then stopped, that pattern tells a careful clinician something important about what may or may not be driving the pain.
These clues can be very specific.
If an epidural steroid injection helped for a couple of weeks, that may suggest regional inflammation was part of the pain pattern.
If a medial branch block gave clear short-term relief, that may point toward facet joint involvement.
Even if physical therapy helped only briefly, the way your body responded can reveal important movement patterns, limitations, or stabilizing muscle issues.
None of these treatments were wasted. They may have acted as temporary spotlights on the deeper source of pain.
Matching Care: The Modern Approach
So, if modern spine care is not just about sending patients through the same loop again, what does it do differently?
Modern spine care is not simply “try harder.”
It is “match the care more carefully.”
It is not repeating the same standard sequence and hoping for a different result. It is tailoring the plan to the patient’s specific risk profile, pain pattern, history, and goals.
Modern options are broader than they used to be.
Stratified care, structured rehabilitation, supported self-management, targeted injections, and newer diagnostic or interventional procedures may all have a role for carefully selected patients.
For example, the PACBACK randomized clinical trial, published in JAMA, found that clinician-supported biopsychosocial self-management produced statistically significant but small reductions in disability compared with guideline-based medical care for adults with acute or subacute low back pain at increased risk of chronic disabling pain.
That matters because it reflects a broader shift in spine care: helping patients build skills, confidence, movement strategies, and self-management tools, rather than relying only on passive treatments.
There are also targeted diagnostic and interventional procedures today that were not part of the conversation a decade ago.
This leads to a crucial question:
Has anyone stepped back and looked at the whole picture?
You may have tried medications, physical therapy, and injections. But were those treatments simply checked off a list? Or did someone connect the dots?
When you are dealing with treatment-resistant pain, “What else should I try?” may not be the best question.
The better question is:
Has my entire treatment history been viewed as one cohesive map?
The Vertrae® Evaluation: A Comprehensive Review
At Vertrae® in Miamisburg, Ohio, Dr. Kamal Woods reviews the full treatment history before recommending any new treatments.
He does not simply look for what failed. He looks at every partial response as valuable data.
The exam, imaging, response patterns, and — most importantly — the patient’s goals all shape the plan moving forward.
When Dr. Woods takes a second look, he actively seeks treatable categories that may have been missed or underrecognized in the past.
That may include findings such as Modic changes, which are specific signal changes in the bone marrow near the disc.
It may also include multifidus dysfunction, in which the deep stabilizing muscles of the spine no longer coordinate or support the spine as effectively as they should.
These are specific patterns that may have dedicated treatment pathways today.
If you were told 10 years ago that nothing more could be done, some of these factors may not have been fully recognized or considered at that time.
Please take this to heart:
A second look after a long journey is not starting over.
It is building on the work that has already been done.
Every step you took, every treatment you tried, and every response that faded may help create the path toward a more focused modern evaluation.
Your history is not just a list of failures.
It is your personalized medical map.
If you have tried many things and the pain is still running the room, a focused evaluation at Vertrae® in Miamisburg, Ohio, may be the next step worth taking seriously.
What if your years of so-called failures are actually the blueprint needed to finally solve your pain puzzle?
Thank you for joining us for this explainer.
Quick Answer:
If you have tried physical therapy, injections, and medications without lasting back pain relief, the next step is often not repeating the same treatments. It is a fresh evaluation that reviews your full treatment history, exam, imaging, pain pattern, and function. Modern options may include risk-matched care, structured rehabilitation, supported self-management, or newer targeted procedures for carefully selected patients.
You are not at the beginning of the journey. You are the patient who has already done the reasonable things. You showed up. You followed the plan. You gave each treatment a fair chance.
And somehow, the pain is still running the room.
One patient described the cycle this way: “I tried many things in search of resolution. Sometimes things work for a while then stop.” Another said it more bluntly: “On my fifth doctor — no help.”
That kind of exhaustion is different. The question is no longer, “What else should I try?” It becomes, “Has anyone actually stepped back and looked at the whole picture?”
A note on the language. “Treatment-resistant” does not mean untreatable. It simply means the pain has not responded in a lasting way to the usual first steps — such as physical therapy, medications, injections, or time. It is a description of where the journey has gone so far. It is not a verdict on what comes next.
“I tried many things in search of resolution. Sometimes things work for a while then stop.” |
“What’s left?” is often actually “What was missed?”
Or, more precisely — what has not been connected yet.
Here is a sentence that is uncomfortable to write and important to read. The list of treatments a patient has tried does not always reflect everything that should have been considered. It often reflects what was tried in the order it was offered.
Most patients with chronic low back pain receive a fairly standard sequence: rest and over-the-counter medication, then physical therapy, then a stronger medication, then maybe an injection, then another round of PT, then something newer. That sequence is reasonable for many people. But for the patient whose pain has not responded, the sequence itself is sometimes the limiting factor. Same approach. Different round. Same plateau.
A 2024 systematic review and meta-analysis of 95 studies, including roughly 18,000 patients, found that low back pain lasting longer than 12 weeks tends to follow a different course than acute low back pain. Pain improves modestly in the first six weeks, then often plateaus. Patients with persistent pain saw only small changes in pain and disability over the following year (Wallwork et al., 2024). That is not a failure of effort. That is a known clinical course — and it is part of why the same playbook on round four may not produce a different outcome than round three.
The more useful question is rarely “What else can we add to the list?” It is, “What does the full picture actually show, and is the plan still matching it?”
Snippet — The plateau is real
For patients whose low back pain has lasted longer than twelve weeks, research shows that pain and disability often plateau and change only modestly over the following year with usual care. Repeating the same sequence of treatments rarely changes the curve. A fresh evaluation — one that connects what previous visits treated separately — may matter more than another round.
Why did some treatments help for a while, then stop?
This is one of the most common things patients say in a spine consultation. “It helped at first, then stopped.” If that has happened, the experience is real — and it is more useful than it may feel.
There are several reasons a treatment can help temporarily and then fade. Some treatments reduce inflammation in a specific area for a few weeks. Some calm an irritated joint, nerve, or disc structure temporarily. Some improve strength or mobility in a way that helps until the underlying pain pattern reasserts itself. And sometimes the nervous system has become sensitized — meaning the pain system stays on alert even after the original trigger has changed.
The point is not that those treatments failed. The point is that temporary relief is information.
If an epidural injection helped for a few weeks, the response says something about whether inflammation in a specific region was part of the story. If a medial branch block produces clear short-term relief, the response suggests whether facet-joint pain may be involved. If a particular physical therapy approach helped briefly and then plateaued, the response can point toward what kind of movement, retraining, or further evaluation might be considered next.
At Vertrae®, that history matters. The question is not only what failed. It is what each response — even a short one — may be telling us.
A failed treatment is not wasted information. It is data. |
What the research says when the usual back pain treatments have not worked
Before looking at newer procedures, it helps to ask a more basic question: what does the research say about people whose back pain does not resolve after the usual first steps? The answer is not “try harder.” The answer is usually “match the care more carefully.”
One-size-fits-all care often falls short
A landmark trial of more than fifteen hundred patients with low back pain compared two approaches in primary care. The first was usual care. The second sorted patients into low-, medium-, and high-risk categories for long-term disability based on a brief screening questionnaire — then matched the intensity of treatment to that risk. The risk-matched group had better disability scores at four months and at twelve months, with greater cost-effectiveness (Hill et al., 2011).
In plain English: the patients most likely to develop chronic disability benefited the most from a plan that took their risk seriously from the start. Patients further along in the journey often share the same risk profile — high pain, multiple failed treatments, and a sense of helplessness — and may benefit from a plan that is matched to that profile rather than another round of the standard sequence.
Better-supported care can outperform standard medical care
In February 2026, JAMA published the PACBACK trial, which enrolled 1,000 adults with acute or subacute low back pain who were already at moderate to high risk of developing chronic low back pain. They were randomized to one of four arms: spinal manipulation alone, supported self-management with a clinician, both combined, or guideline-based medical care. Followed for a full year, the supported self-management arms produced statistically significant reductions in disability compared with medical care. Sixty-seven percent of patients in the supported self-management group achieved a 50% or greater reduction in disability — compared with 54% in the medical care group (Bronfort et al., 2026).
“Supported self-management” is not “you’re on your own.” In the PACBACK study it meant working with a physical therapist or chiropractor over eight weeks to address the physical, psychological, and social pieces of pain together — movement, pacing, fear, sleep, and goals. It is structured. It is clinician-supported. It works.
For patients far down the road, multidisciplinary rehabilitation has the strongest evidence
A Cochrane systematic review of forty-one trials, totaling nearly seven thousand patients with chronic low back pain — most of whom had pain for over a year and had failed previous treatments — found that multidisciplinary biopsychosocial rehabilitation reduced pain and disability compared with usual care. Patients who completed it were also more likely to be working one year later than those who received physical treatments alone (Kamper et al., 2015). This kind of program is rarely the first thing offered. For patients who have already tried many things, it is often the most evidence-supported next step.
Opioids are usually not the answer for nonspecific low back pain
If a previous doctor offered opioids and the patient declined or stopped early, that instinct may have been correct. The OPAL trial, published in The Lancet, randomized adults with acute low back or neck pain to a short course of an opioid medication or to placebo. The trial did not show a statistically significant pain benefit over placebo at six weeks, and the opioid group reported more side effects (Jones et al., 2023). The trial concluded that opioids should not be recommended for acute non-specific low back pain. For chronic axial low back pain, the case for routine opioid use is even weaker.
If your pain has started traveling into your leg
Sciatica follows a different pathway than axial (back-only) low back pain. A randomized trial in the Annals of Internal Medicine found that early structured physical therapy improved disability in patients with acute sciatica, with benefits still measurable at 1 year (Fritz et al., 2021). If your symptoms have changed from back-only pain to leg pain, or if leg pain comes and goes, that is a meaningful change — and it should be discussed during evaluation.
Snippet — What patients search for
Patients often search for phrases like “nothing works for my back pain,” “back pain after PT and injections,” or “new treatments for chronic low back pain” because they are trying to name the same experience: they have done the usual things, and the pain is still shaping their life.
Modern options for chronic back pain are broader than they used to be
Modern spine care is not one ladder where every patient climbs from PT to injections to surgery. It is more like a map. Different pain patterns point toward different pathways. The job of an evaluation is to figure out which pathway fits the patient, not to push every patient down the same path.
Some options were not widely available, not commonly used for these patterns, or not part of the standard conversation when many patients first heard “nothing more can be done.” Each one carries indications, selection criteria, and careful evaluation. None is positioned as the answer.
Non-surgical and rehabilitation pathways
- Risk-matched care plans, where the intensity of treatment is matched to the patient’s risk of long-term disability.
- Clinician-supported self-management, structured programs that work on movement, pacing, fear, sleep, and goals together over several weeks.
- Multidisciplinary biopsychosocial rehabilitation, team-based programs combining physical activity with psychological and behavioral support — often the most evidence-supported next step for chronic patients who have failed earlier care.
- Individualized walking and movement programs, with progressive education and pacing, supported by recent randomized trial evidence.
Targeted diagnostic and interventional pathways
- Diagnostic injections, used to test whether a specific structure (such as a facet joint or sacroiliac joint) is contributing to pain.
- Vertebrogenic (endplate-driven) pain evaluation. Modern imaging can identify a specific pattern of bone marrow signal changes near the disc — sometimes called Modic changes — that is associated with chronic low back pain in some patients. There are now treatment options targeted to this pattern, including basivertebral nerve ablation, for patients who meet specific criteria.
- Facet or SI joint workup, when the pattern of symptoms suggests one of these joints may be a source.
Neuromodulation and restorative options for selected patients
- Restorative neurostimulation for multifidus dysfunction. The deep stabilizing muscles of the lower spine can lose normal coordination after an earlier injury. ReActiv8® is a device-based therapy designed to help retrain those muscles for appropriately selected patients. Vertrae® has dedicated content covering ReActiv8® in depth.
- Modern spinal cord stimulation. Newer waveforms of spinal cord stimulation have changed conversations that used to end at “we have nothing left.” Selection criteria are specific. Not every patient is a candidate.
- Dorsal root ganglion stimulation, for certain nerve-related pain patterns where conventional approaches have not produced lasting relief.
Surgical and motion-preserving options when appropriate
- Minimally invasive, motion-preserving procedures. When surgery does become part of the conversation — because structural findings match symptoms and conservative care has not produced lasting relief — the philosophy at Vertrae® is MotionFirst™: minimally invasive techniques designed to preserve motion when appropriate.
None of these is offered as a first step. None replaces a thorough evaluation. They exist on the menu — a menu that is broader today than it was when many patients last had a real conversation about their options.
Were you told years ago that nothing more could be done?
If your last serious conversation about back pain treatment happened five, ten, or fifteen years ago and ended with “we have tried what we have,” that conversation may be worth reopening.
The pathways above were not widely available, not commonly used for these patterns, or not part of the standard conversation when many patients first heard “nothing more can be done.” Diagnostic frameworks have evolved as well. Modic changes, multifidus dysfunction, and specific nerve-related pain patterns are looked for more carefully now, and several have associated treatment pathways that were not on the table before.
This does not mean a new procedure is right for everyone. Every option has indications and selection criteria. It does mean that an answer from years ago may deserve another look.
If you are a patient who stopped looking, this is the door to look again. Request a consultation at vertrae.com.
At Vertrae®, your past treatments become part of the diagnosis
At Vertrae®, a patient with years of treatment history is not treated like a blank slate — nor as a “failed” patient. That history is data.
Which injection helped for two weeks? Which medication caused side effects, and at what dose? Which physical therapy exercises made symptoms worse? Which movements improved confidence? Which treatment gave clear short-term relief, and which gave none at all? Those details matter — because they can point toward what has already been ruled out, what may have been under-treated, and what deserves a more targeted look.
Dr. Kamal Woods, MD, MBA, is dual fellowship-trained in minimally invasive spine surgery, with training that includes Cedars-Sinai. An evaluation at Vertrae® in Miamisburg, Ohio for the experienced patient does not start over from zero. It builds on the work that has already been done.
A more thorough look may include:
- A careful read of the full treatment history. Which therapies were tried, in what order, with what response, for how long. Each response — partial, short-lived, or absent — is read as diagnostic information.
- A hands-on exam. How the spine moves. Where it is tender. How the nerves test. How specific motions reproduce or relieve the pain.
- A second look at the imaging — not just the report. Woods reviews the actual images alongside the radiologist’s narrative, and reads them in the context of what the patient feels and how they move. Patterns associated with newer treatable categories — such as Modic changes or multifidus changes — are specifically sought.
- A real conversation about what comes next. Sometimes the next step is a more targeted study. Sometimes it is a structured rehabilitation program. Sometimes it is a procedure that was not part of the conversation when an earlier doctor said there was nothing left. Sometimes it is the honest conversation that an option being considered elsewhere is unlikely to help in this specific situation.
This is the through-line of MotionFirst™ spine care: a thorough evaluation, the full range of options laid out clearly, and the patient — not the procedure menu — at the center of the decision.
|
You are not starting over. You are bringing evidence. |
One thing that does not change — even with the best plan
Recovery, for patients with long histories of treatment-resistant pain, is shaped by the patient as much as by the procedure or program. The patients who do best are the ones who stay engaged with the team, follow the plan as best they can, and communicate openly about what is and is not working. None of that is “you should have tried harder.” It is the recognition that care is a partnership.
The Vertrae® team — Dr. Woods, the nursing staff, the rehabilitation partners — walks alongside the patient. The patient is not expected to figure it out alone, but recovery works best when the plan is clear, realistic, and shared.
What this does not mean
This article is not saying that every patient who has tried PT, injections, and medications needs a procedure. It does not mean every newer treatment is right for every person. And it is not saying the earlier care was wrong.
It is saying that chronic back pain deserves a careful reset. The goal is to review what has already been tried, understand what each treatment response tells us, and match the next step to the actual pain pattern — not just repeat the same sequence.
A fresh look at Vertrae® may end with a procedure recommendation. It may end with a structured rehabilitation plan. It may end with a clearer conversation about what to watch and what to try next — sometimes the most valuable outcome is knowing which treatments are unlikely to help in a specific situation.
Key Takeaway
If you have tried physical therapy, injections, and medications without lasting relief, you are not the patient who needs another round of the same. The current evidence supports risk-matched care, supported self-management, and — when appropriate — newer procedures that were not commonly part of the conversation a decade ago. The most useful next step is often a fresh evaluation that reads your full treatment history as data, alongside the imaging, the exam, and how the pain behaves in real life.
Listen to This Topic: What Modern Spine Care Looks Like When the Usual Treatments Have Not Worked
Prefer to listen? This episode breaks down what to do when physical therapy, injections, and medications have already been tried without lasting relief. In a clear, conversational format, we discuss why some treatments help for a while and then stop working, what the research says about treatment-resistant low back pain, the broader range of modern options now available, and when a thorough second look may help patients find a clearer path forward.
Read the Full Podcast Transcript
DISCLAIMER:
Transcript lightly edited for clarity and readability. The conversational format is designed to explore concepts and tradeoffs, not to provide medical advice or apply to any individual patient. Outcomes vary by patient, pain pattern, technology used, and study population, and findings from one clinical trial may not generalize to every situation. For guidance specific to your situation, consult a spine specialist.
TRANSCRIPT TEXT:
Speaker 1:
Three rounds of physical therapy. Two epidural injections. Gabapentin. Cymbalta. A medial branch block.
If you can read that list and recognize most of it, this deep dive is for you.
Speaker 2:
Absolutely. Because you are not at the beginning of the journey.
You are the patient who has already done the reasonable things. You showed up. You followed the plan. You gave each treatment a fair chance. And somehow, the pain is still running the room.
Speaker 1:
Right. It is still dominating everything.
Speaker 2:
Exactly.
So today, our goal is to unpack this. We are looking at a comprehensive clinical framework from Vertrae® alongside recent research on stratified care, supported self-management, and modern spine treatment pathways.
And we want to answer one specific question:
When you have tried almost everything, what is actually left?
Speaker 1:
That may be the most important question at this stage.
For the listener who is years into this journey, the goal has fundamentally shifted. It is no longer about finding the next random treatment to cross off a procedural checklist.
The goal is to step back, take a breath, and finally look at the whole picture.
Speaker 2:
It is a completely different paradigm of care.
Speaker 1:
It really is.
And I want to talk about what that experienced patient often looks like when they walk into a clinic today. Because they are not simply wandering in with a sudden ache in the lower back.
Speaker 2:
Not at all.
They are walking in carrying the weight of their medical history.
In many clinics, the experienced patient arrives with a physical binder.
Speaker 1:
Tabs and everything.
Speaker 2:
Exactly. They may have a color-coded spreadsheet of dates and dosages. They may bring a printed pharmacy list. It is, in many ways, a detailed inventory of their own suffering.
Speaker 1:
That is a powerful way to put it.
Early in a back pain journey, a patient may ask, “What else should I try?”
But by the time they have compiled that binder, the exhaustion is palpable. And the question shifts to, “Has anyone actually stepped back and connected all these dots?”
Speaker 2:
There is a quote from the Vertrae® clinical overview that captures that exhaustion. A patient said, “I tried many things in search of resolution. Sometimes things work for a while, then stop.”
And another simply stated, “On my fifth doctor. No help.”
Speaker 1:
Let’s unpack this. Because it can feel like walking into an accountant’s office with a shoebox full of receipts. But instead of taxes, it is a history of physical pain.
Speaker 2:
Exactly. You hand over the shoebox, and you are hoping someone knows how to read the paperwork.
Unfortunately, when you hand that metaphorical shoebox to the standard medical system, the system may give you a label: treatment resistant.
Speaker 1:
I want to pause on that phrase, “treatment resistant.”
Because if I am a patient and a doctor puts that in my chart, it sounds like a final diagnosis for my spine. It can sound like a polite way of saying, “You are broken, and we cannot fix this.”
Speaker 2:
And that is a major misunderstanding.
Treatment resistant is not a verdict on your future. It is a description of where the journey has gone so far.
All it means is that the usual first-line steps did not produce lasting relief.
Speaker 1:
That is it?
Speaker 2:
That is it.
It does not mean the pain is untreatable. And it certainly does not mean it is time to give up.
Speaker 1:
So when patients hear “treatment resistant,” they may think their body is failing. But it may actually mean the usual treatment sequence has been exhausted.
Speaker 2:
Precisely.
Let’s look at the data here. A large 2024 systematic review and meta-analysis by Wallwork and colleagues looked at the clinical course of low back pain across 95 studies, including nearly 18,000 patients.
Speaker 1:
That is a significant amount of data.
Speaker 2:
It is.
The review found a clear pattern around the 12-week mark.
Speaker 1:
What happens at 12 weeks?
Speaker 2:
In the first several weeks, acute low back pain often improves. The body’s natural healing mechanisms are active.
But if pain persists past the 12-week mark and transitions from acute to persistent or chronic pain, the recovery curve often flattens.
The researchers found that patients with persistent low back pain who received usual care often saw only modest changes in pain and disability over the following year.
Speaker 1:
So if someone is past that 12-week mark and their doctor says, “Let’s do another six weeks of physical therapy, maybe another steroid injection, and adjust the medication,” they may be running an acute pain playbook on a persistent pain problem.
Speaker 2:
Exactly. The sequence itself can become a trap.
Rest, over-the-counter medications, physical therapy, stronger medications, injection, then back to physical therapy — that can be a reasonable sequence for a new acute injury.
Speaker 1:
Like if someone tweaked their back helping a friend move a couch.
Speaker 2:
Exactly.
But for the chronic pain patient, repeating that same approach often produces the same plateau.
That is a known clinical reality. It is not a failure of your willpower or your body.
Speaker 1:
That distinction is important, because patients internalize that failure.
Speaker 2:
All the time.
They may think, “I did not do my core exercises correctly,” or “I must have ruined the injection somehow.”
But the data may be telling a different story: the standard sequence has been exhausted.
Speaker 1:
Which brings us back to that shoebox of receipts.
All those treatments in the binder that did not cure the pain — are we saying they were a waste of time?
Speaker 2:
Not at all.
This is one of the most important shifts in modern spine care.
When we analyze why a treatment helped briefly and then stopped, we may uncover valuable diagnostic information.
Speaker 1:
I want to think about this like troubleshooting a complex system. Maybe a car.
If my car’s headlights keep dying, and I replace a fuse, and the headlights work perfectly for 10 minutes before blowing the fuse again, I did not fix the car.
But I did prove that the electrical system is where the problem likely lives.
Speaker 2:
That is a helpful analogy. And it is very similar to how we should view many spine interventions.
Partial or temporary responses can be diagnostic data.
Speaker 1:
They are clues.
Speaker 2:
Exactly. They are not noise, and they are not failures.
One of the most common things patients say in clinic is, “It helped at first, then stopped.”
The old paradigm may write that off.
The newer paradigm looks closer.
If an epidural injection gave you a few weeks of meaningful relief and then faded, that may suggest localized inflammation or nerve irritation was part of the pain pattern.
If a medial branch block provided clear short-term relief, that may point toward facet joint involvement.
Speaker 1:
So temporary relief can suggest the clinician was aiming at a relevant target, even if the treatment was not designed to be a permanent fix.
Speaker 2:
Exactly.
Or it may show that one layer of pain was addressed, while another structural or nervous system issue remains active underneath.
For example, if physical therapy helped you regain some motion but then you hit a hard plateau, that can tell us what kinds of movement or mechanical loads your spine tolerates — and where your boundaries are.
Speaker 1:
That changes the way a patient can look at their history.
Speaker 2:
It really does.
Your past treatments are clues. They are not defeats.
Every time you tried a therapy and got even temporary relief, you may have generated useful clinical information about your body.
And once a clinical team starts viewing your past treatments as data rather than dead ends, the entire landscape changes.
Speaker 1:
The standard repetitive ladder of treatments becomes a much more specific map.
Speaker 2:
Exactly.
Speaker 1:
So let’s unfold that map.
If the answer is not “try the same sequence again, but harder,” what does modern care look like?
Let’s start with how clinicians decide which treatment fits which patient.
I saw the STarT Back trial in the source material. That was published in The Lancet. What did that trial do differently?
Speaker 2:
The STarT Back trial moved away from a one-size-fits-all sequence.
It looked at more than 1,500 patients and compared usual care with a risk-matched approach.
Speaker 1:
Risk-matched? How do you measure who is at higher risk for long-term back pain problems?
Speaker 2:
It goes deeper than a simple pain scale.
The STarT Back approach uses a screening tool to categorize patients into low-, medium-, and high-risk groups for long-term disability.
The tool looks at physical symptoms, but it also considers psychosocial factors such as fear of movement, anxiety about pain, and mood.
Speaker 1:
So it is not just asking someone to rate pain from one to ten.
Speaker 2:
Correct.
The trial showed that when patients were matched with care based on their risk profile, outcomes improved and care was more cost-effective compared with non-stratified usual care.
Speaker 1:
That makes sense.
Risk matching works when you identify the right patient early. But what if someone is already years into this? What if the nervous system is already stuck in the “on” position?
Speaker 2:
That brings us to newer research, including the PACBACK trial published in JAMA in 2026.
The PACBACK trial studied adults with acute or subacute low back pain who were at moderate to high risk of chronic disabling pain. It compared guideline-based medical care with spinal manipulation, clinician-supported biopsychosocial self-management, and a combination approach.
Speaker 1:
I have to be honest: “biopsychosocial self-management” sounds like a phrase that could be misunderstood as, “Deal with it yourself.”
Speaker 2:
It does sound like jargon, but that is not what it means.
Clinician-supported biopsychosocial self-management is not about leaving the patient alone. It means helping the patient address the physical, emotional, behavioral, and lifestyle factors that can influence low back pain.
That may include movement, fear of reinjury, sleep, stress, function, and confidence.
Speaker 1:
So it is not saying the pain is “just psychological.”
Speaker 2:
Exactly. It is recognizing that pain is biological, mechanical, neurological, and influenced by the whole person.
In PACBACK, clinician-supported biopsychosocial self-management produced statistically significant but small reductions in disability compared with medical care over one year. The difference in pain intensity was not statistically significant.
Speaker 1:
That is a careful but important distinction.
It may help function and disability, even if pain scores do not dramatically change.
Speaker 2:
Exactly.
For experienced patients, that distinction matters. Sometimes the first goal is not eliminating every sensation overnight. It may be improving function, confidence, movement tolerance, sleep, and daily life.
Speaker 1:
Speaking of next steps, I noticed something missing from the evidence-supported list: opioids.
If someone is in severe chronic pain, why not just use stronger painkillers?
Speaker 2:
For many back pain scenarios, the long-term data and guideline trends do not support relying on opioids as the central solution.
The OPAL trial, published in The Lancet, studied adults with acute low back or neck pain and compared a short course of an opioid with placebo.
At six weeks, the opioid group did not show a statistically significant pain benefit over the placebo group, and adverse effects were more common.
Speaker 1:
So opioids did not outperform placebo for pain in that acute back and neck pain trial.
Speaker 2:
Correct.
Opioids can mask pain temporarily for some patients, but they do not correct the underlying mechanical, inflammatory, or nervous system drivers of pain. For some people, long-term opioid use can also create additional risks.
Speaker 1:
So if a patient previously declined opioids or tried them and felt they were not the answer, that instinct may be supported by the research.
Speaker 2:
Exactly.
Speaker 1:
We have talked about risk-matched care and supported self-management for the nervous system.
But what about structural issues? Because sometimes it is not only a sensitive nervous system. Sometimes there is a physical or mechanical contributor in the spine.
Speaker 2:
Absolutely.
The diagnostic framework for structural spine pain has evolved significantly in the last decade. Clinicians can now identify certain physical patterns that were not always recognized or treatable in the past.
Speaker 1:
Like what?
Speaker 2:
A good example is vertebrogenic pain.
Speaker 1:
Vertebrogenic meaning pain originating from the vertebrae themselves?
Speaker 2:
Specifically, pain associated with the vertebral endplates, where the disc meets the bone.
Modern MRI can sometimes identify specific bone marrow signal changes near the disc, called Modic changes.
Speaker 1:
Modic changes.
Speaker 2:
Right.
For a long time, Modic changes might be noted on an MRI report without a clear treatment pathway. Today, for carefully selected patients, there are targeted procedures such as basivertebral nerve ablation.
Speaker 1:
If I can use an analogy, it sounds like trying to fix a creaky floorboard by constantly changing the carpet, when the actual issue may be the wooden joist underneath.
Speaker 2:
That is a helpful way to think about it.
In vertebrogenic pain, the pain signal may be coming from deeper structures near the vertebral endplates. Basivertebral nerve ablation is designed to target the specific nerve pathway transmitting those pain signals in selected patients.
Speaker 1:
So the goal is to quiet the pain signal closer to the source.
Speaker 2:
Exactly.
Speaker 1:
What else is on the modern map? The source material mentions ReActiv8®.
Speaker 2:
ReActiv8® addresses a different problem: multifidus muscle dysfunction.
The multifidus muscles are deep stabilizing muscles that run along the lower spine. After a back injury or prolonged pain, those muscles can weaken, atrophy, or lose normal coordination.
Speaker 1:
So even after the initial injury heals, the stabilizers may still be offline.
Speaker 2:
Exactly.
Standard physical therapy can help many people, but in some cases, the body compensates by recruiting larger outer muscles instead of restoring deep stabilizer function.
ReActiv8® is a restorative neurostimulation therapy designed to stimulate the nerves that activate the multifidus muscle. The goal is to help restore neuromuscular control and improve spinal stability over time.
Speaker 1:
So it is not the same as a standard TENS unit someone buys at the pharmacy.
Speaker 2:
Correct.
TENS is generally used for sensory pain modulation. ReActiv8® is focused on motor control and restorative activation of the multifidus muscle.
Speaker 1:
That is an important distinction.
Are there other nerve targets? The source also mentions dorsal root ganglion stimulation.
Speaker 2:
Yes. The dorsal root ganglion, or DRG, is a small bundle of nerves near the spinal cord that helps relay sensory signals from specific regions of the body.
Imagine the spinal cord as a major highway. The DRG is like an on-ramp for sensory signals from a specific region.
Speaker 1:
So instead of stimulating the entire highway, you can target a specific on-ramp where pain signals enter.
Speaker 2:
Exactly.
DRG stimulation may be considered for certain types of focal, localized neuropathic pain, depending on the patient and diagnosis.
Speaker 1:
When we connect this to the bigger picture, the larger point is that the menu of options is much broader and more sophisticated today than it was even a decade ago.
Speaker 2:
Yes. When a patient with a complex history is told there is nothing left to try, sometimes it means the care team has not fully updated the map.
The answer is not “try harder.”
The answer is “match the care more carefully.”
Speaker 1:
I love that.
So what does this mean for the listener who has a binder full of medical history? How do they prepare for a fresh evaluation that actually uses their data?
Speaker 2:
They should seek a clinical team that views an extensive treatment history as a strategic asset, not a burden.
A thorough evaluation for an experienced patient does not start over from zero. It builds on the foundation of the work that has already been done.
Speaker 1:
So the patient is not walking in as a blank slate. They are walking in as someone bringing hard-earned evidence about their own body.
Speaker 2:
Exactly.
This is central to the approach at Vertrae®. Dr. Kamal Woods, a dual fellowship-trained spine surgeon with training that includes Cedars-Sinai, regularly evaluates patients with complex, persistent back pain histories.
The Vertrae® evaluation is built around a motion-first philosophy.
Speaker 1:
Motion-first meaning the goal is not automatically to fuse the spine or eliminate movement.
Speaker 2:
Right.
The goal is to preserve motion whenever structurally appropriate and put the patient’s functional goals at the center of the decision.
During a fresh evaluation, the care team takes a detailed look at the treatment timeline.
They want to know what helped for two weeks, what did nothing, what caused side effects, and what changed the patient’s function.
They combine that history with a hands-on exam to understand how the spine moves and functions.
They also take a second look at the imaging, actively seeking treatable categories such as Modic changes, vertebrogenic pain patterns, or multifidus dysfunction — rather than relying solely on an old radiology summary.
Speaker 1:
So it requires a genuine partnership.
Speaker 2:
It does.
Sometimes, Dr. Woods may find that a targeted procedure is the missing piece.
Sometimes the evidence points toward structured rehabilitation or a plan that addresses the nervous system.
And sometimes the most valuable outcome is an honest, evidence-based conversation about what to stop trying.
Speaker 1:
That is powerful.
Knowing what will not work can be just as empowering as knowing what might.
Speaker 2:
Exactly.
The patient is no longer expected to solve the puzzle alone.
Speaker 1:
That is empowering.
If you have been at this for a while, if the pain is still running the room, if you have a binder full of treatments, and if you are tired of asking, “What else should I try?” — there may be value in asking a different question:
Has anyone actually stepped back and looked at the whole picture?
Dr. Kamal Woods and the team at Vertrae® see patients across Miamisburg, Dayton, and Southwest Ohio.
You can request a focused evaluation at Vertrae.com.
Speaker 2:
Before we go, consider this final thought:
There is power in viewing your physical history not as a list of defeats, but as a deeply personalized medical journal waiting for the right translator.
Speaker 1:
If your past treatments were not failures, but partially decoded messages pointing toward the next answer, what else in your health might be raw data waiting to be fully understood?
Ready to Understand What Your Options Actually Are? Request an Evaluation at Vertrae®
If you have tried physical therapy, injections, and medications, and still feel like no one has connected the dots, you do not have to keep cycling through the same playbook. A thorough second look may help clarify what has been tried, what has changed, what may have been missed, and what options fit the full picture now.
No referral required. No commitment to any procedure from the evaluation.
Serving: Dayton • Miamisburg • Centerville • Kettering • Beavercreek • Springboro • West Chester • Cincinnati • Southwest Ohio
Vertrae® Surgery Center: Spine-exclusive outpatient facility • same-day discharge • no general hospital environment
Dr. Kamal Woods, MD, MBA: Dual fellowship-trained neurosurgeon • Cedars-Sinai trained • Mazor X™ robotic-assisted surgery • exclusively minimally invasive spin
→ Visit vertrae.com or call to request your MotionFirst™ evaluation today.
Frequently Asked Questions
I’ve tried PT, injections, and medications. What’s actually left for chronic back pain?
More options than many patients realize. Risk-matched care plans, clinician-supported self-management programs, structured walking programs, multidisciplinary rehabilitation, and newer procedures targeted to specific pain patterns may all be considered. The next step depends on the full picture — history, exam, imaging, and how pain behaves in real life.
Why did my back pain treatment work at first, then stop working?
Temporary relief can happen when a treatment reduces inflammation, calms an irritated joint or nerve, or improves movement for a short time without fully addressing the main pain driver. That response is still useful information. A spine specialist can use it to better understand what may be contributing to the pain.
Does trying many treatments mean my back pain is hopeless?
No. It means the usual first steps have not produced lasting relief. Chronic back pain often needs an individualized plan that considers the full treatment history, exam, imaging, function, and pain pattern. For some patients, newer options or a different type of rehabilitation may be appropriate.
I was told years ago that nothing more could be done. Is it worth getting another opinion?
It may be. Diagnostic frameworks and treatment options have expanded over the last ten to fifteen years. Patterns associated with newer treatable categories — such as Modic changes or multifidus dysfunction — are now looked for more carefully. A fresh evaluation can identify whether any of these apply to a specific situation.
I had spine surgery years ago, and I’m in pain again — is there anything new?
There may be. Some treatment categories that exist today — including newer forms of neuromodulation and targeted procedures for specific pain patterns — were not widely available or commonly used a decade ago. A specialist evaluation can help determine whether any newer option may be appropriate.
My doctor offered opioids for my back pain. Should I take them?
Current evidence does not support routine opioid use for non-specific low back pain. A randomized trial in The Lancet did not find a statistically significant pain benefit over placebo for acute low back pain at six weeks, with more side effects in the opioid group. Other approaches typically come first.
What is supported self-management for back pain?
Supported self-management is a structured program where a clinician — often a physical therapist — works with a patient over several weeks on the physical, psychological, and social pieces of pain together. A 2026 trial in JAMA found this approach reduced disability more than standard medical care for patients at risk of chronic pain.
What is risk-matched care for low back pain?
Risk-matched care uses a brief screening tool to sort patients into low, medium, or high risk of long-term disability, then matches the intensity of treatment to the risk. A 2011 trial in The Lancet found this approach produced better outcomes and was more cost-effective than usual primary care, especially for higher-risk patients.
When should I get a second opinion from a spine specialist?
A second opinion may help when several treatments have not produced lasting relief, when the imaging report and the pain do not seem to match, or when daily life keeps shrinking around the pain. It may especially help if the last serious conversation about treatment options happened more than a few years ago.
References (APA 7th Edition)
Bronfort, G., Meier, E. N., Leininger, B., Schneider, M., Evans, R., Greco, C., Hanson, L., McFarland, C., Chou, R., Connett, J., Delitto, A., George, S. Z., Glick, R. M., Keefe, F., Licciardone, J., Schulz, C., Turk, D., & Heagerty, P. J. (2026). Spinal manipulation and clinician-supported biopsychosocial self-management for acute back pain: The PACBACK randomized clinical trial. JAMA, 335(6), 497–510. https://doi.org/10.1001/jama.2025.21990
Fritz, J. M., Lane, E., McFadden, M., Brennan, G., Magel, J. S., Thackeray, A., Minick, K., Meier, W., & Greene, T. (2021). Physical therapy referral from primary care for acute back pain with sciatica: A randomized controlled trial. Annals of Internal Medicine, 174(1), 8–17. https://doi.org/10.7326/M20-4187
Hill, J. C., Whitehurst, D. G. T., Lewis, M., Bryan, S., Dunn, K. M., Foster, N. E., Konstantinou, K., Main, C. J., Mason, E., Somerville, S., Sowden, G., Vohora, K., & Hay, E. M. (2011). Comparison of stratified primary care management for low back pain with current best practice (STarT Back): A randomised controlled trial. The Lancet, 378(9802), 1560–1571. https://doi.org/10.1016/S0140-6736(11)60937-9
Jones, C. M. P., Day, R. O., Koes, B. W., Latimer, J., Maher, C. G., McLachlan, A. J., Billot, L., Shan, S., & Lin, C. C. (2023). Opioid analgesia for acute low back pain and neck pain (the OPAL trial): A randomised placebo-controlled trial. The Lancet, 402(10398), 304–312. https://doi.org/10.1016/S0140-6736(23)00404-X
Kamper, S. J., Apeldoorn, A. T., Chiarotto, A., Smeets, R. J. E. M., Ostelo, R. W. J. G., Guzman, J., & van Tulder, M. W. (2015). Multidisciplinary biopsychosocial rehabilitation for chronic low back pain: Cochrane systematic review and meta-analysis. BMJ, 350, h444. https://doi.org/10.1136/bmj.h444
Pocovi, N. C., Lin, C. C., French, S. D., Graham, P. L., van Dongen, J. M., Latimer, J., Merom, D., Tiedemann, A., Maher, C. G., Clavisi, O., Tong, S. Y. K., & Hancock, M. J. (2024). Effectiveness and cost-effectiveness of an individualised, progressive walking and education intervention for the prevention of low back pain recurrence in Australia (WalkBack): A randomised controlled trial. The Lancet, 404(10448), 134–144. https://doi.org/10.1016/S0140-6736(24)00755-4
Wallwork, S. B., Braithwaite, F. A., O’Keeffe, M., Travers, M. J., Summers, S. J., Lange, B., Hince, D. A., Costa, L. O. P., Menezes Costa, L. C., Chiera, B., & Moseley, G. L. (2024). The clinical course of acute, subacute and persistent low back pain: A systematic review and meta-analysis. CMAJ, 196(2), E29–E46. https://doi.org/10.1503/cmaj.230542
